Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.

Farkash I, Feferman T, Cohen-Saban N, Avraham Y, Morgenstern D, Mayuni G, Barth N, Lustig Y, Miller L, Shouval DS, Biber A, Kirgner I, Levin Y, Dahan R

Open source

DOI
10.1016/j.celrep.2021.110114
Published
2021 Dec 14
Container
Cell reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.celrep.2021.110114,
  title = {Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.},
  author = {Farkash I and Feferman T and Cohen-Saban N and Avraham Y and Morgenstern D and Mayuni G and Barth N and Lustig Y and Miller L and Shouval DS and Biber A and Kirgner I and Levin Y and Dahan R},
  year = {2021},
  journal = {Cell reports},
  doi = {10.1016/j.celrep.2021.110114},
  url = {https://doi.org/10.1016/j.celrep.2021.110114}
}

RIS

TY  - JOUR
TI  - Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.
AU  - Farkash I
AU  - Feferman T
AU  - Cohen-Saban N
AU  - Avraham Y
AU  - Morgenstern D
AU  - Mayuni G
AU  - Barth N
AU  - Lustig Y
AU  - Miller L
AU  - Shouval DS
AU  - Biber A
AU  - Kirgner I
AU  - Levin Y
AU  - Dahan R
PY  - 2021
JO  - Cell reports
DO  - 10.1016/j.celrep.2021.110114
UR  - https://doi.org/10.1016/j.celrep.2021.110114
ER  -

APA

I, F., T, F., N, C., Y, A., D, M., G, M., N, B., Y, L., L, M., DS, S., A, B., I, K., Y, L., & R, D. (2021). Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.. Cell reports. https://doi.org/10.1016/j.celrep.2021.110114

Source records